These results, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the strategy of targeting ACKR3 as a unique strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked Issues. (three) Except if the affected https://jessicah517mjd7.dreamyblogs.com/profile